SPRY R&D Expenses
Ars Pharmaceuticals Inc · R&D Expenses
SPRY R&D Expenses
Latest reported$15.23Mperiod ending
SPRY R&D Expenses ($14.80M → $15.23M)
Annual R&D Expenses
High-resolution chart · PNG
SPRY r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 13,181,000 | |
| 19,580,000 | |
| 20,266,000 | |
| 18,376,000 | |
| 20,273,000 | |
| 14,070,000 | |
| 21,505,000 | |
| 14,804,000 |